LFSC · F/m Emerald Life Sciences Innovation ETF · Documents ETF
$43.47
+0.35 (+0.82%)
At close · Oct 28
Return incl. dividend (before tax)
Volume · Oct 28
711
Avg daily vol (3M)
3420
SEC filings belong to the fund's registrant and can cover sibling fund series as well as this exchange listing. They are shown most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| PRE 14A | On August 20, 2026, T. Rowe Price Group, Inc. agreed to acquire F/m Investments LLC, triggering shareholder votes on replacement advisory agreements for The RBB Fund, Inc. funds; the Board expects unchanged management, strategies, personnel and advisory fees. | 2026-10-23 | 2027-01-12 | |
| DEFR14A | — | 2026-06-18 | — | |
| DEF 14A | — | 2026-05-19 | 2026-06-22 | |
| PRE 14A | — | 2026-04-20 | 2026-06-22 | |
| DEFA14A | — | 2025-11-14 | — | |
| DEFR14A | — | 2024-08-13 | — | |
| DEF 14A | — | 2024-08-09 | 2024-09-27 | |
| PRE 14A | — | 2024-07-26 | — | |
| DEFA14A | — | 2023-04-21 | — | |
| DEFA14A | — | 2023-03-28 | — | |
| DEF 14A | — | 2023-03-09 | 2022-03-28 | |
| PRE 14A | — | 2023-02-24 | — | |
| DEFA14A | — | 2021-03-18 | — | |
| DEFA14A | — | 2021-03-03 | — | |
| DEF 14A | — | 2021-03-01 | 2021-05-06 | |
| PRE 14A | — | 2021-02-16 | — |
Showing 1–16 of 16 filings